Neurogene (NGNE) Shares Issued (2014 - 2026)
Neurogene (NGNE) reported Shares Issued of $201000.0 for Q1 2026, up 957.89% on a YoY basis from $19000.0 in Q1 2025, and up 102.05% quarter-over-quarter from -$9.8 million in Q4 2025.
Neurogene (NGNE) Shares Issued (2014 - 2026) Analysis & Trends
Neurogene has reported Shares Issued for 13 years, with the latest figure at $201000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued rose 957.89% year-over-year to $201000.0; the trailing twelve-month figure through Mar 2026 stood at $182000.0 (up 129.84% YoY), and the FY2023 full-year result was $168000.0, changed N/A from the prior year.
- Shares Issued for Q1 2026 stood at $201000.0, up from -$9.8 million in the prior quarter.
- The five-year high for Shares Issued was $9.7 million in Q3 2025, with the low at -$9.8 million in Q4 2025.
- Historically, Shares Issued has averaged $26357.1 across 5 years, with a median of $51500.0 in 2023.
- The largest YoY upside for Shares Issued was 1975.0% in 2024 against a maximum downside of 3082.86% in 2024.
- Neurogene's Shares Issued stood at -$134000.0 in 2022, then soared by 100.75% to $1000.0 in 2023, then sank by 104500.0% to -$1.0 million in 2024, then plunged by 838.7% to -$9.8 million in 2025, then surged by 102.05% to $201000.0 in 2026.
- The last three Shares Issued figures came in at $201000.0 (Q1 2026), -$9.8 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | 201,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Dec 31, 2025 | -9.80 Mn |
| Dec 31, 2025 | -9.80 Mn |
| Sep 30, 2025 | 9.71 Mn |
| Sep 30, 2025 | 9.71 Mn |
| Jun 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Sep 30, 2024 | -1.04 Mn |
| Sep 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 415,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |